Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial
Introduction Alternative drugs and diagnostics are needed for the treatment and control of schistosomiasis. The exclusive use of praziquantel (PZQ) in mass drug administration programmes may result in the emergence of drug resistance. PZQ has little activity against Schistosoma larvae, thus reinfect...
Main Authors: | Emmanuel Bottieau, Achilleas Tsoumanis, Yven Van Herrewege, Diana Arango, Christophe Burm, Badara Cisse, Souleymane Mboup, Clémentine Roucher, Isabel Brosius, Moustapha Mbow, Babacar Thiendella Faye, Annelies De Hondt, Bart Smekens, Linda Paredis, Idzi Potters, Katja Polman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/6/e047147.full |
Similar Items
-
Neuromuscular Signalling Systems in the Blood Fluke, Schistos and Masoni
by: Atkinson, L. E.
Published: (2010) -
Dirofilaria repens Nematode Infection with Microfilaremia in Traveler Returning to Belgium from Senegal
by: Idzi Potters, et al.
Published: (2018-09-01) -
Physiology and biochemistry of mouse small intestine following the infection with schisto soma mansoni
by: Jengesa, B. P.
Published: (1976) -
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis
by: Reto Rufener, et al.
Published: (2018-08-01) -
Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
by: Lynn Meurs, et al.
Published: (2012-01-01)